Status:
COMPLETED
Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Lead Sponsor:
University of California, San Francisco
Conditions:
Morbid Obesity
Weight Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Morbid obesity and its associated metabolic diseases are on the rise in the United States. Currently, the best treatment for obesity is bariatric surgery where both roux-en-Y gastric bypass and sleeve...
Detailed Description
The most effective weight loss procedures in the United States are both roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)where the majority are performed laparoscopically. Estimated excess b...
Eligibility Criteria
Inclusion
- Previous Roux-En-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG)
- Failure to lose \>50% of their excess body weight after 1 year
- Failure of weight loss despite maximal medical therapy and medically-supervised diets
Exclusion
- Esophageal Stricture
- Marginal Ulcer at the gastrojejunostomy anastomosis
- Non-compliance with bariatric follow-up
- Gastric ulcers
- Paraesophageal hernias
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01871896
Start Date
January 1 2014
End Date
June 1 2022
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143